This opportunity funds small clinical trials to obtain critical data on next-generation devices for recording and modulating the human central nervous system. Supported studies may involve Non-Significant Risk or Significant Risk devices, including chronic implants requiring FDA Investigational Device Exemptions. The trials aim to answer key questions about device function or design that cannot be addressed through non-clinical testing. Devices may be sourced through the BRAIN Public-Private Partnership, facilitating access to novel technologies for clinical research.
Eligible applicants include state, county, city, and tribal governments, small and for-profit businesses, public and private institutions of higher education, nonprofits with or without 501(c)(3) status, and public housing authorities. Eligibility is broad across government and organizational types.
